Compare NSLR & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NSLR | NAGE |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | 117 |
| Industry | Finance: Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.4M | 269.2M |
| IPO Year | 2011 | N/A |
| Metric | NSLR | NAGE |
|---|---|---|
| Price | $11.31 | $3.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 291.7K | ★ 660.0K |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16.51 |
| Revenue Next Year | N/A | $14.58 |
| P/E Ratio | ★ N/A | $21.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.61 | $3.18 |
| 52 Week High | $12.19 | $11.58 |
| Indicator | NSLR | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 51.66 |
| Support Level | N/A | $3.57 |
| Resistance Level | N/A | $4.04 |
| Average True Range (ATR) | 0.00 | 0.14 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 0.00 | 84.95 |
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.